January’s JP Morgan Healthcare Conference set the tone for the year ahead, and whi...
January’s JP Morgan Healthcare Conference set the tone for the year ahead, and whi...
As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...
Antibody-drug conjugates have arisen as a groundbreaking class of targeted cancer therapies,...
The pharmaceutical and healthcare industries are experiencing a transformation driven by the...
We delivered market insights and a VP Finance shortlist, supporting a Swiss oncology biotech...
We placed 135 hires in 4 years, enabling In Vivo department growth and meeting preclinical d...
We supported 57 hires over five years, driving CRO expansion, market share growth, and reput...
We placed 19 contractors in Patient Outcomes roles, enhancing strategies and advancing produ...